Next Article in Journal
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
Next Article in Special Issue
Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis, Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent
Previous Article in Journal
Augmenting the Activity of Monoterpenoid Phenols against Fungal Pathogens Using 2-Hydroxy-4-methoxybenzaldehyde that Target Cell Wall Integrity
Previous Article in Special Issue
Structural Diversity of Copper(II) Complexes with 9-Deazahypoxanthine and Their in Vitro SOD-Like Activity
Open AccessArticle

Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells

by Tao Zhang 1,†, Haojie Lu 2,†, Weijun Li 3, Ronggui Hu 3,4,* and Zi Chen 5,*
1
Department of Laboratory Medicine, Huashan Hospital, Fudan University, 12 Central Urumqi Road, Shanghai 200040, China
2
Shanghai Cancer Center and Key Laboratory of Glycoconjugates Research Ministry of Public Health, Fudan University, Shanghai 200032, China
3
State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China
4
Cancer Research Center, SIBS-Xuhui Central Hospital, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China
5
Department of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Kaixun Huang
Int. J. Mol. Sci. 2015, 16(11), 26871-26879; https://doi.org/10.3390/ijms161125994
Received: 7 July 2015 / Revised: 23 October 2015 / Accepted: 30 October 2015 / Published: 10 November 2015
(This article belongs to the Special Issue Applied Bioinorganic Chemistry and Selected Papers from 13th ISABC)
The identification of arsenic direct-binding proteins is essential for determining the mechanism by which arsenic trioxide achieves its chemotherapeutic effects. At least two cysteines close together in the amino acid sequence are crucial to the binding of arsenic and essential to the identification of arsenic-binding proteins. In the present study, arsenic binding proteins were pulled down with streptavidin and identified using a liquid chromatograph-mass spectrometer (LC-MS/MS). More than 40 arsenic-binding proteins were separated, and redox-related proteins, glutathione S-transferase P1 (GSTP1), heat shock 70 kDa protein 9 (HSPA9) and pyruvate kinase M2 (PKM2), were further studied using binding assays in vitro. Notably, PKM2 has a high affinity for arsenic. In contrast to PKM2, GSTP1and HSPA9 did not combine with arsenic directly in vitro. These observations suggest that arsenic-mediated acute promyelocytic leukaemia (APL) suppressive effects involve PKM2. In summary, we identified several arsenic binding proteins in APL cells and investigated the therapeutic mechanisms of arsenic trioxide for APL. Further investigation into specific signal pathways by which PKM2 mediates APL developments may lead to a better understanding of arsenic effects on APL. View Full-Text
Keywords: arsenic-binding protein; arsenic-biotin; acute promyelocytic leukaemia; LC-MS/MS; pyruvate kinase M2 arsenic-binding protein; arsenic-biotin; acute promyelocytic leukaemia; LC-MS/MS; pyruvate kinase M2
Show Figures

Figure 1

MDPI and ACS Style

Zhang, T.; Lu, H.; Li, W.; Hu, R.; Chen, Z. Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells. Int. J. Mol. Sci. 2015, 16, 26871-26879.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop